The development of diagnostic systems to assess and classify persons with communicative disorders, particularly etiologic systems leading to molecular genetics studies, is a key research target of NIDCD (National Strategic Research Plan, 1993). This research program is specifically concerned with these goals for the estimated 3 percent - 8 percent (approximately 4.8 million) children in this country with speech disorders of unknown origin. The research plan for the next period has three specific aims: to validate a phenotype marker for a genetically transmitted subtype of child speech disorders, to cross-validate a descriptive-explanatory model relating otitis media with effusion (OME) and hearing loss from 6-18 months to speech-language deficits at ages 3-6, and to explicate acoustic-phonetic correlates of reduced intelligibility in children with histories of significant OME. A total of 15 data sets will use speech information from 2,773 children from clinical-research facilities in six states. Project I: Speech-Genetics Studies has three project strands: (a) an epidemiologic study to estimate the prevalence of speech delay in kindergarten children, providing liability estimates for behavioral and molecular genetics research; (b) cross-sectional studies to test the optimum phenotype marker for speech delay in genetics studies-a broad- domain (core verbal trait disorder) marker using measures of phonological processing (i.e., phonological awareness) or a narrow- domain marker based on alternative productive speech metrics; and (c) longitudinal studies to determine whether normalization of speech disorder is associated with familial aggregation, with implications for genetic versus environmental regulation. Collaborative molecular genetics studies at three sites will test the alternative phenotypes. Project II: Speech-Otitis Media Studies has five project strands: (a) statistical modeling studies to identify sources of variance in unintelligibility in relation to OME, hearing loss, and speech-language variables; (b) acoustic correlate studies to describe and explicate acoustic contrastivity features associated with OME and lowered intelligibility; (c) structural equation modeling studies to characterize how OME and hearing loss at 6-18 months moderate and mediate later speech delay; (d) case studies using auditory-perceptual and acoustic-phonetic methods to describe intelligibility differences in children with speech delays before, during, and after episodes of OME; and (e) longitudinal studies to determine the course of normalization from 3-6 years of intelligibility deficits associated with early recurrent OME.

Agency
National Institute of Health (NIH)
Institute
National Institute on Deafness and Other Communication Disorders (NIDCD)
Type
Research Project (R01)
Project #
5R01DC000496-12
Application #
6174893
Study Section
Special Emphasis Panel (ZRG2-BPO (03))
Program Officer
Cooper, Judith
Project Start
1988-07-01
Project End
2003-06-30
Budget Start
2000-07-01
Budget End
2001-06-30
Support Year
12
Fiscal Year
2000
Total Cost
$357,708
Indirect Cost
Name
University of Wisconsin Madison
Department
Pediatrics
Type
Other Domestic Higher Education
DUNS #
161202122
City
Madison
State
WI
Country
United States
Zip Code
53715
Snijders Blok, Lot; Rousseau, Justine; Twist, Joanna et al. (2018) CHD3 helicase domain mutations cause a neurodevelopmental syndrome with macrocephaly and impaired speech and language. Nat Commun 9:4619
Shriberg, Lawrence D; Strand, Edythe A; Fourakis, Marios et al. (2017) A Diagnostic Marker to Discriminate Childhood Apraxia of Speech From Speech Delay: I. Development and Description of the Pause Marker. J Speech Lang Hear Res 60:S1096-S1117
Shriberg, Lawrence D; Strand, Edythe A; Fourakis, Marios et al. (2017) A Diagnostic Marker to Discriminate Childhood Apraxia of Speech From Speech Delay: Introduction. J Speech Lang Hear Res 60:S1094-S1095
Shriberg, Lawrence D; Strand, Edythe A; Fourakis, Marios et al. (2017) A Diagnostic Marker to Discriminate Childhood Apraxia of Speech From Speech Delay: IV. The Pause Marker Index. J Speech Lang Hear Res 60:S1153-S1169
Shriberg, Lawrence D; Strand, Edythe A; Fourakis, Marios et al. (2017) A Diagnostic Marker to Discriminate Childhood Apraxia of Speech From Speech Delay: III. Theoretical Coherence of the Pause Marker with Speech Processing Deficits in Childhood Apraxia of Speech. J Speech Lang Hear Res 60:S1135-S1152
Shriberg, Lawrence D; Strand, Edythe A; Fourakis, Marios et al. (2017) A Diagnostic Marker to Discriminate Childhood Apraxia of Speech From Speech Delay: II. Validity Studies of the Pause Marker. J Speech Lang Hear Res 60:S1118-S1134
Truong, D T; Shriberg, L D; Smith, S D et al. (2016) Multipoint genome-wide linkage scan for nonword repetition in a multigenerational family further supports chromosome 13q as a locus for verbal trait disorders. Hum Genet 135:1329-1341
Mueller, Kathryn L; Murray, Jeffrey C; Michaelson, Jacob J et al. (2016) Common Genetic Variants in FOXP2 Are Not Associated with Individual Differences in Language Development. PLoS One 11:e0152576
Evans, P D; Mueller, K L; Gamazon, E R et al. (2015) A genome-wide sib-pair scan for quantitative language traits reveals linkage to chromosomes 10 and 13. Genes Brain Behav 14:387-97
Strand, Edythe A; Duffy, Joseph R; Clark, Heather M et al. (2014) The Apraxia of Speech Rating Scale: a tool for diagnosis and description of apraxia of speech. J Commun Disord 51:43-50

Showing the most recent 10 out of 66 publications